Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
about
Differential mitochondrial toxicity screening and multi-parametric data analysisMolecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cellsCarvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy.Dexrazoxane as a cardioprotectant in children receiving anthracyclinesAn Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialDexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseRole of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity.Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.Dexrazoxane mitigates epirubicin-induced genotoxicity in mice bone marrow cells.
P2860
Q28484406-7D8A505E-2AA5-4713-91AF-8A0D06B0E328Q33578496-A287B384-8B43-4E9B-98A9-785D4D699526Q35014803-71E6702C-9A32-40D9-B685-9DCD41947824Q35391254-C4982861-43F3-4682-8DFF-7D35A9117006Q35583768-29371CDF-CA0F-4CC4-8AB1-5A2CBDA59651Q36415905-7B40A3A7-4A90-4591-A0A4-067DAFDF472AQ36568908-78DA66AE-F384-45CA-B390-CFB47BA292E6Q37129069-98AD7E44-B51F-4BAC-9DA2-0AD39BFC3037Q37569911-4173BE0C-7E74-4038-8DE9-9BE6DC7DCEBCQ39608341-4F591E4B-D9AF-4C94-BA65-3F06D6D25B3FQ39636367-68FC0131-FA46-4BC9-BAEA-6F961DCFFDA7Q41717594-299F7E9A-F222-456A-B4DF-E451DEF56366Q42708190-2345F4D0-A97F-404D-A1D6-9838D4D05B34Q43495742-0375EF99-FC7F-405E-B413-7DD2DF8CD802Q46592609-339B106E-2532-4B28-A750-ADFC19337EF9Q46612630-C017C3FD-3292-4CD0-8CAA-4EFBB377D8A4
P2860
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dexrazoxane-afforded protectio ...... ytes from apoptotic cell death
@en
Dexrazoxane-afforded protectio ...... tes from apoptotic cell death.
@nl
type
label
Dexrazoxane-afforded protectio ...... ytes from apoptotic cell death
@en
Dexrazoxane-afforded protectio ...... tes from apoptotic cell death.
@nl
prefLabel
Dexrazoxane-afforded protectio ...... ytes from apoptotic cell death
@en
Dexrazoxane-afforded protectio ...... tes from apoptotic cell death.
@nl
P2093
P2860
P50
P356
P1476
Dexrazoxane-afforded protectio ...... ytes from apoptotic cell death
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605192
P407
P577
2009-07-21T00:00:00Z